Welcome to LookChem.com Sign In|Join Free

CAS

  • or

500128-99-4

Post Buying Request

500128-99-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

500128-99-4 Usage

General Description

(E)-5-(2-(thiophen-2-yl)vinyl)-1H-pyrazole is a chemical compound with the molecular formula C11H8N2S. It belongs to the class of pyrazole derivatives and contains a thiophene ring and a vinyl group. Pyrazole derivatives have been found to have various biological activities, including anti-inflammatory, analgesic, and antimicrobial properties. The (E)-5-(2-(thiophen-2-yl)vinyl)-1H-pyrazole compound may have potential applications in pharmaceutical research and drug development due to its structural features and potential biological activities. Further study and research into this compound may reveal its potential therapeutic uses in various medical conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 500128-99-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,0,1,2 and 8 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 500128-99:
(8*5)+(7*0)+(6*0)+(5*1)+(4*2)+(3*8)+(2*9)+(1*9)=104
104 % 10 = 4
So 500128-99-4 is a valid CAS Registry Number.

500128-99-4Downstream Products

500128-99-4Relevant articles and documents

IMPROVING RENAL FUNCTION AFTER KIDNEY TRANSPLANTATION

-

, (2021/05/07)

Provided herein are methods of improving kidney function after renal transplantation comprising administering (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole.

SOLID FORMS OF (E)-3-[2-(2-THIENYL)VINYL]-1H-PYRAZOLE

-

Paragraph 00332-00333, (2020/10/21)

The present disclosure provides solid forms of (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole, compositions thereof, and methods of making and using the same.

SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY

-

Page 91-92, (2010/02/07)

The present invention provides compounds having formula (I) and pharmaceutically acceptable derivatives thereof, wherein R1, R2 and B are as described generally and n classes and subclasses herein, and additionally provides pharmaceu

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 500128-99-4